Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID LEE SHRINER

Allopathic & Osteopathic Physicians Dermatology

NPI
1609884915
CMS profile
117767
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$1,896.02

  • Reported across 100 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$290.11

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $290.11 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $143.93 7
Lilly USA, LLC $39.06 2
Dermavant Sciences, Inc. $38.34 2
REVANCE THERAPEUTICS, INC. $27.23 1
Boehringer Ingelheim Pharmaceuticals, Inc. $22.95 1
ConvaTec Inc. $18.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $260.93 18
PY2019 $315.25 19
PY2020 $45.77 2
PY2022 $590.66 30
PY2023 $393.30 17
PY2024 $290.11 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.10 01/05/2024 Food and Beverage Undisputed 01/23/2026 1106093160 CMS
ABBVIE INC. $19.69 02/26/2024 Food and Beverage Undisputed 01/23/2026 1106093162 CMS
ABBVIE INC. $17.54 04/11/2024 Food and Beverage Undisputed 01/23/2026 1106093164 CMS
ABBVIE INC. $19.98 05/16/2024 Food and Beverage Undisputed 01/23/2026 1106093166 CMS
ABBVIE INC. $22.32 06/12/2024 Food and Beverage Undisputed 01/23/2026 1106093168 CMS
ABBVIE INC. $25.98 09/11/2024 Food and Beverage Undisputed 01/23/2026 1106093170 CMS
ABBVIE INC. $18.32 11/13/2024 Food and Beverage Undisputed 01/23/2026 1106093172 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.95 01/11/2024 Food and Beverage Undisputed 01/23/2026 1118079716 CMS
ConvaTec Inc. $18.60 06/25/2024 Food and Beverage Undisputed 01/23/2026 1151384905 CMS
Dermavant Sciences, Inc. $13.74 01/17/2024 Food and Beverage Undisputed 01/23/2026 1127933573 CMS
Dermavant Sciences, Inc. $24.60 05/02/2024 Food and Beverage Undisputed 01/23/2026 1127933576 CMS
Lilly USA, LLC $19.61 01/26/2024 Food and Beverage Undisputed 01/23/2026 1136157319 CMS
Lilly USA, LLC $19.45 02/23/2024 Food and Beverage Undisputed 01/23/2026 1136132842 CMS
REVANCE THERAPEUTICS, INC. $27.23 09/09/2024 Food and Beverage Undisputed 01/23/2026 1147929241 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.